Sohini Das &Amp;Amp; Samie Modak

Stories by Sohini Das &Amp;Amp; Samie Modak

Heard about side-pocketing in MFs?

Heard about side-pocketing in MFs?

Rediff.com   7 Feb 2019

Sebi has allowed mutual fund schemes the option of 'side-pocketing' which move will help both fund houses and investors.

New deal with Subhash Chandra gives lenders more control over Zee

New deal with Subhash Chandra gives lenders more control over Zee

Rediff.com   5 Feb 2019

Zee and its lenders had decided to enter into an agreement to not offload the pledged shares amid a sharp slide in the prices of the underlying securities during end-Janury. The terms give the lenders a greater say, upside benefit from the proposed strategic sale, more cover and personal guarantee.

Why brokers are unhappy with revised stamp duty norms

Why brokers are unhappy with revised stamp duty norms

Rediff.com   2 Feb 2019

'Rather than abolishing stamp duty as STT is already levied on all transactions, the government has de-facto imposed a state STT in the guise of stamp duty'

MFs have high exposure to Zee group cos, hit hard by stock crash

MFs have high exposure to Zee group cos, hit hard by stock crash

Rediff.com   28 Jan 2019

Debt funds have exposure of nearly Rs 8,000 crore to Zee group papers. Aditya Birla MF, HDFC MF, Franklin Templeton MF, and ICICI Prudential MF have the highest exposure, reports Samie Modak.

Credit Suisse bets big on industrial stocks

Credit Suisse bets big on industrial stocks

Rediff.com   14 Jan 2019

'Our preference remains for the less-expensive industrial stocks, which are showing good earnings momentum.'

Jio likely to grab 51% revenue market share in 3 years

Jio likely to grab 51% revenue market share in 3 years

Rediff.com   7 Jan 2019

Airtel and Vodafone Idea are also trying to expand the penetration of 4G users in their subscriber base as they take this network to the hinterland

Wow! Indian stock market world's 7th biggest

Wow! Indian stock market world's 7th biggest

Rediff.com   2 Jan 2019

All the countries in the top 10 have seen a decline in market value.

Road will be bumpy for investors in 2019

Road will be bumpy for investors in 2019

Rediff.com   29 Dec 2018

'The first half of 2019 could be volatile.' 'In the second half, volatility inducing events should be largely behind us.'

Rough ride for markets in 2018

Rough ride for markets in 2018

Rediff.com   27 Dec 2018

2018 has been a disappointing and highly volatile year for equity investors.

Brokers send Budget wishlist to Sebi

Brokers send Budget wishlist to Sebi

Rediff.com   24 Dec 2018

'Extensive thought has been put in, and we have pondered over each and every suggestions and demands received from our members.'

Will the Sensex climb to the magical 40,000-mark in 2019?

Will the Sensex climb to the magical 40,000-mark in 2019?

Rediff.com   19 Dec 2018

French investment bank BNP Paribas said India's earnings growth potential is around 14-15 per cent

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com   6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Rediff.com   9 Nov 2018

Singh, who was instrumental in building required capabilities in the organisation said his role at Fortis did not allow him to spend time with his family, as the reason behind his resignation.

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com   1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

India's skewed growth story

India's skewed growth story

Rediff.com   19 Oct 2018

More than 90 per cent of India's population belongs to the base tier (less than $10,000, or about Rs 730,000) when it comes to the distribution of wealth.

Why drug firms' Q2 revenue growth is likely to dip

Why drug firms' Q2 revenue growth is likely to dip

Rediff.com   12 Oct 2018

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com   10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

2018 gains wiped out from Indian markets

2018 gains wiped out from Indian markets

Rediff.com   8 Oct 2018

Slide in the rupee, surging oil prices, and rising bond yields have triggered the latest fall in the market.

Markets stare at worst-ever FPI sell-off in 2018

Markets stare at worst-ever FPI sell-off in 2018

Rediff.com   5 Oct 2018

Not just India, but Asian peers such as Indonesia, South Korea, Thailand, Taiwan and The Philippines have seen sharp FPI outflows this year

Midcaps, smallcaps see biggest monthly fall since October 2008

Midcaps, smallcaps see biggest monthly fall since October 2008

Rediff.com   1 Oct 2018

'The velocity of the market correction in September was so fierce that 9 stocks declined for every one that advanced,' reveals Samie Modak.